Avantor, Inc. (AVTR)
Supplies chemicals, lab equipment, and services that drug makers and scientists need to develop medicines and run experiments.
$11.76+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+3.5%
The outlook
AVTR trades at $11.76, sitting above both its 50- and 200-day moving averages after a modest gain today. Analyst consensus leans Hold with an average target about 11% below the current price. The stock sits roughly midway in its 52-week range, with a StockGlow score tilted bullish at 63/100.
What’s behind the score
Analyst consensusHold — 2.9 avg of 16 analysts
Price trendAbove its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Price targetAvg target -11% vs current price
Analyst price target
~12-month · 16 analysts$10.44average target-11.2% vs now
Now $11.76
Low $7.00High $19.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$8.03B
52-wk high
$15.93
52-wk low
$7.27
50-day avg
$9.70
200-day avg
$10.23
Trailing P/E
—